International Petroleum Corporation Publishes Prospectus for Bond Listing on Euronext Oslo Børs

International Petroleum Corporation Publishes Prospectus for Bond Listing on Euronext Oslo Børs GlobeNewswire February 05, 2026 TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) — International Petroleum Corporation (“IPC” or the “Corporation”) (TSX, Nasdaq Stockholm: IPCO) announces that the Swedish Financial Supervisory Authority today approved the prospectus in connection with the listing on Euronext Oslo Børs of […]

PLUG Investors Have Opportunity to Lead Plug Power Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Plug Power Inc. (“Plug Power” or “the Company”) (NASDAQ: PLUG) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who

CRWV Investors Have Opportunity to Lead CoreWeave, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CoreWeave, Inc. (“CoreWeave” or “the Company”) (NASDAQ: CRWV) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the

FRMI Investors Have Opportunity to Lead Fermi Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fermi Inc. (“Fermi” or “the Company”) (NASDAQ: FRMI) for violations of the federal securities laws. Investors who purchased the Company’s securities pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s

Varonis Systems, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – VRNS

The DJS Law Group reminds investors of a class action lawsuit against Varonis Systems, Inc. (“Varonis ” or “the Company”) (NASDAQ: VRNS ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of VRNS during

CoreWeave, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – CRWV

The DJS Law Group reminds investors of a class action lawsuit against CoreWeave, Inc. (“CoreWeave ” or “the Company”) (NASDAQ: CRWV ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CRWV during the

VRNS Investors Have Opportunity to Lead Varonis Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Varonis Systems, Inc. (“Varonis” or “the Company”) (NASDAQ: VRNS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased

ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased

HanchorBio Accelerates Global Clinical Footprint with Multiple Oral and Poster Presentations in Q1 2026

Sustained execution and high-impact data across HanchorBio's next-generation immuno-oncology portfolio to be featured at ASCO-GI, AACR-IO, ESMO-TAT, ICNHO, and WOC HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company pioneering transformative immunotherapies, today announced a robust schedule of scientific presentations at major international oncology congresses throughout Q1 2026. The selection of multiple abstracts, including four

Banle Group Hosts Inaugural ESG Forum with Industry Leaders, Pioneering Green Shipping Solutions Amid Global Decarbonization Push

Banle Group ('Banle' or the 'Group'), a leading Asia-Pacific marine fuel logistics provider, hosted its landmark inaugural ESG Forum – "Charting the New Horizon: Powering Green Shipping with Sustainable Fuels" – uniting top maritime executives, financiers, legal experts, and climate scientists to address the shipping industry's urgent decarbonization challenges on February 2. Speaker Lineup Tackles

Scroll to Top